Patents
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
02/1999
02/02/1999US5866124 Antiidiotypic antibodies for high molecular weight-melanoma associated antigen
02/02/1999US5866123 Gene encoding cationic amino acid transporter protein
02/02/1999US5866117 Genetic engineering
02/02/1999CA2169987C Gel form of a vaccine
02/02/1999CA1340373C Cloning and sequencing of the dna fragment which codes for the five subunits of the pertussis toxin, a hybrid plasmid containing the dna fragment and micro-organisms transformed by the hybrid plasmid and capable of expressing all or some of the subunits of the pertussis toxin
02/02/1999CA1340372C Production of e. coli lt-b enterotoxin subunit
02/01/1999CA2238672A1 Seca
02/01/1999CA2238670A1 A novel smad3 splice variant as a target in chronic renal failure, atherosclerosis and fibrosis
01/1999
01/29/1999CA2239266A1 Novel histidine kinase
01/28/1999WO1999004265A2 Cancer associated nucleic acids and polypeptides
01/28/1999WO1999004237A2 Diagnosis of spongiform encephalopathies using prionins
01/28/1999WO1999004040A1 Methods for diagnosis and treating cancers, and methods for identifying pathogenic markers in a sample of normal cells
01/28/1999WO1999004029A2 A swine hepatitis e virus and uses thereof
01/28/1999WO1999004018A1 Chimeric contraceptive vaccines
01/28/1999WO1999004011A2 Hiv-1 group o antigens and uses thereof
01/28/1999WO1999004010A1 Nucleic acid vaccines encoding g protein of respiratory syncytial virus
01/28/1999WO1999004009A1 Method of dna vaccination using dna encoding antigen and encoding il6
01/28/1999WO1999004008A2 Cloned genomes of infectious hepatitis c viruses and uses thereof
01/28/1999WO1999003992A1 Trail receptor
01/28/1999WO1999003989A1 Human atp-binding cassette transport protein
01/28/1999WO1999003987A2 Syncytial respiratory virus epitopes and antibodies comprising them, useful in diagnosis and therapy
01/28/1999WO1999003972A1 Cytotoxic t lymphocytes
01/28/1999WO1999003885A1 Antitumoral composition based on immunogenic polypeptide with modified cell location
01/28/1999WO1999003875A1 Nucleotide sequence of the nucleocapsid gene of oropouche virus
01/28/1999WO1999003871A1 Hexadecasaccharide-protein conjugate vaccine for shigella dysenteriae type 1
01/28/1999WO1999003502A1 LO-CD2a ANTIBODY AND USES THEREOF FOR INHIBITING T CELL ACTIVATION AND PROLIFERATION
01/28/1999WO1999003501A1 Immunogenic conjugates comprising a group b meningococcal porin and an h. influenzae polysaccharide
01/28/1999WO1999003500A1 Improved vaccines and method therefor
01/28/1999WO1999003499A1 Cellular vesicle called ''exosome'', preparation and use thereof in immune stimulation
01/28/1999WO1999003490A1 Proteins and peptides for contraceptive vaccines and fertility diagnosis
01/28/1999WO1998049333A3 Eukaryotic gene expression cassette and uses thereof
01/28/1999WO1998049303A3 Compositions and methods for conferring tick immunity and preventing tick borne diseases
01/28/1999WO1998048000A3 A cell strain with activated anti-cancer cytotoxic activity
01/28/1999WO1998047530A3 Coupling of unmodified proteins to haloacyl or dihaloacyl derivatized polysaccharides for the preparation of protein-polysaccharide vaccines
01/28/1999CA2297072A1 Immunogenic conjugates comprising a group b meningococcal porin and an h. influenzae polysaccharide
01/28/1999CA2296736A1 Syncytial respiratory virus epitopes and antibodies comprising them, useful in diagnosis and therapy
01/28/1999CA2296447A1 Human atp-binding cassette transport protein
01/28/1999CA2296442A1 Hiv-1 group o antigens and uses thereof
01/28/1999CA2296089A1 Nucleic acid vaccines encoding g protein of respiratory syncytial virus
01/28/1999CA2295926A1 Methods for diagnosis and treating cancers, and methods for identifying pathogenic markers in a sample of normal cells
01/28/1999CA2295719A1 Trail receptor
01/28/1999CA2295552A1 Cloned genomes of infectious hepatitis c viruses and uses thereof
01/28/1999CA2237155A1 A yak-1 related serine/threonine protein kinase-htlar33
01/27/1999EP0893507A1 Use of MHC class II ligands (CD4 and LAG-3) as adjuvant for vaccination and of LAG-3 in cancer treatment
01/27/1999EP0893505A2 Novel glucose kinase
01/27/1999EP0893504A1 Polypeptide coded by the Kaposi sarcoma-associated virus (KSHV, HHV-8) and its uses in diagnostic and therapy
01/27/1999EP0893503A2 Regulator protein from Staphylococcus aureus
01/27/1999EP0893502A2 GreA from Staphylococcus aureus
01/27/1999EP0893501A2 Ferrichrome transport atp-binding protein
01/27/1999EP0893500A2 BmrU gene from Staphylococcus aureus
01/27/1999EP0893499A2 Tetracycline resistance protein from Staphylococcus aureus
01/27/1999EP0893498A2 cDNA clone MY1 that encodes a novel human 7-transmembrane receptor
01/27/1999EP0893496A2 Histidyl tRNA synthetase from Chlamydia trachomatis
01/27/1999EP0893495A2 Isoleucyl tRNA synthetase from Chlamydia trachomatis
01/27/1999EP0893494A2 Aspartyl tRNA synthetase from Chlamydia trachomatis
01/27/1999EP0893493A2 Genetically modified cells and their use for prophylaxis or treatment of diseases
01/27/1999EP0893450A1 Chromatographic method for high yield purification and viral inactivation of antibodies
01/27/1999EP0893124A1 Pharmaceutical combination preparations comprising human monoclonal antibodies for the treatment of chronic hepatitis B and a virostatic substance
01/27/1999EP0892643A1 Methods for inhibiting an immune response by blocking the gp39/cd40 and ctla4/cd28/b7 pathways and compositions for use therewith
01/27/1999EP0892640A2 Enteric-coated pharmaceutical compositions of mycophenolate
01/27/1999EP0542770B1 Random bio-oligomer library, a method of synthesis thereof, and a method of use thereof
01/27/1999EP0461177B1 Human intra-acrosomal sperm antigen for use in a contraceptive vaccine
01/27/1999CN1206350A Hybrid with interferon-'alpha' and immunoglobulin Fc linkes through non-immunogenic peptide
01/27/1999CN1205897A Deativation vaccine for cholera fowl emulsion and its preparation
01/26/1999US5864027 HIV envelope polypeptides
01/26/1999US5864019 Antigen-binding protein comprising: 3 or 4 vh domains; spacing polypeptide attached to c-terminal end of each vh domain; linkage polypeptide containing linkable residues attached to c-terminal end of each spacing polypeptide; vl domain
01/26/1999US5864008 Peptides derived from foot-and-mouth disease virus, pharmaceutical compositions, and methods for using the peptides
01/26/1999US5863944 Compounds and compositions for delivering active agents
01/26/1999US5863890 Smooth muscle relaxants; anticoagulants; vasodilation; protein regulation; cellular metabolism; blood oxygen transport
01/26/1999US5863804 Monoclonal or polyclonal antibodies obtained by administering to an animal a synthetic peptide or a recombinant protein fragment having a partial sequence of t-cadherin, isolating from animal's serum
01/26/1999US5863796 Immunizing a mammal with specific polypeptide and collecting the antibody
01/26/1999US5863787 Kaposi's sarcoma-associated herpesvirus (KSHV) glycoprotein B (GB) and uses thereof
01/26/1999US5863780 A polynucleotide sequence encodes human protein kinase polypeptide; culture product
01/26/1999US5863779 UBC7-like ubiquitin-conjugating enzyme
01/26/1999US5863777 DNA encoding alanyl tRNA synthetase from streptococcus pneumonine
01/26/1999US5863769 DNA encoding interleukin-1 receptor antagonist (IL-1raβ)
01/26/1999US5863766 Isolated, pure polynucleotide encoding a polypeptide for treating vesicle trafficking, immunological, and neoplastic disorders.
01/26/1999US5863757 An expression vector comprising polynucleotide having an open reading frame operably linked to a promoter and encoding a specific polypeptide
01/26/1999US5863755 Nucleic acid encoding novel receptor-type phosphotyrosine phosphatase-κ
01/26/1999US5863745 Contacting cells targeted to be killed with a cytotoxic amount of an antibody-pe40 recombinant fusion protein, wherein said antibody is a single-chain fv fragment (scfv) and said pe40 is a pseudomonas exotoxin fragment
01/26/1999US5863739 Assay and kit for the detection of α platelet derived growth factor receptor
01/26/1999US5863735 Human transmembrane 4 superfamily protein
01/26/1999US5863718 Small peptides which inhibit to T-4 receptors and act as immunogens
01/26/1999US5863543 Camp factor of streptococcus uberis
01/26/1999US5863542 Recombinant attenuated ALVAC canaryopox virus containing heterologous HIV or SIV inserts
01/26/1999US5863541 Proteins in cells
01/26/1999US5863537 Polypeptide comprising a variable region having the amino acid sequence of the variable region selected from the group consisting of h25d2h-1, h25d2h-2, h25d2h-3, h25d2h-4 and h25d2h-5
01/26/1999US5863528 Porcine cytokines
01/26/1999US5863517 Process for the preparation of an organ-specific substance labeled with technetium-99m
01/26/1999CA2137639C Vaccine composition comprising autologous epidermal growth factor or a fragment or a derivate thereof having anti-tumor activity and use thereof in the therapy of malignant diseases
01/26/1999CA2005291C Feline infectious peritonitis virus diagnostic tools
01/26/1999CA1340353C Compositions and methods for removal of detergents
01/26/1999CA1340350C Monoclonal antibody to the 75 kd subunit of the human interleukin-2 receptor and use thereof
01/25/1999CA2238664A1 Novel regulator
01/25/1999CA2238655A1 Cdna clone my1 that encodes a novel human 7-transmembrane receptor
01/24/1999CA2238658A1 Novel grea
01/23/1999CA2238682A1 Novel asps
01/23/1999CA2238679A1 Novel phes
01/23/1999CA2238677A1 Novel iles
01/23/1999CA2238674A1 Novel tetracycline resistance protein